Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

DeFor TE et al. – The authors are introducing the MCI which may have higher discriminating and predictive power for overall survival and NRM. Validation of the HCT–CI and the MCI in larger and separate cohorts of HCT recipients is still needed.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address